학술논문

INTERIM RESULTS OF PHASE 1/2A CLINICAL STUDY OF AR-501, AN INVESTIGATIONAL INHALED FORMULATION OF GALLIUM CITRATE BEING EVALUATED AS AN ANTIBACTERIAL IN CYSTIC FIBROSIS PATIENTS
Document Type
Journal
Source
PEDIATRIC PULMONOLOGY; OCT 2020, 55 pS151-pS152, 2p. Supplement: 2
Subject
Language
English
ISSN
10990496